Australia markets closed

Prelude Therapeutics Incorporated (PRLD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0900+0.0500 (+1.24%)
At close: 04:00PM EDT
4.0900 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.42-0.42-1.68-1.42
Low estimate-0.46-0.46-1.84-1.86
High estimate-0.39-0.37-1.54-0.99
Year ago EPS-0.54-0.45-2.02-1.68
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.63-0.58-0.49-0.48
Actual EPS-0.54-0.45-0.46-0.42
Difference0.090.130.030.06
Surprise %14.30%22.40%6.10%12.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.42-1.68-1.42
7 days ago-0.42-0.42-1.68-1.42
30 days ago-0.49-0.51-2-1.62
60 days ago-0.49-0.51-2-1.62
90 days ago-0.47-0.49-1.92-1.48
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3332
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesPRLDIndustrySector(s)S&P 500
Current qtr.22.20%N/AN/AN/A
Next qtr.6.70%N/AN/AN/A
Current year16.80%N/AN/AN/A
Next year15.50%N/AN/AN/A
Next 5 years (per annum)30.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A